Tyrosine Kinase ETK/BMX Is Up-Regulated in Bladder Cancer and Predicts Poor Prognosis in Patients with Cystectomy

Deregulation of the non-receptor tyrosine kinase ETK/BMX has been reported in several solid tumors. In this report, we demonstrated that ETK expression is progressively increased during bladder cancer progression. We found that down-regulation of ETK in bladder cancer cells attenuated STAT3 and AKT activity whereas exogenous overexpression of ETK had opposite effects, suggesting that deregulation of ETK may attribute to the elevated activity of STAT3 and AKT frequently detected in bladder cancer. The survival, migration and invasion of bladder cancer cells were significantly compromised when ETK expression was knocked down by a specific shRNA. In addition, we showed that ETK localizes to mitochondria in bladder cancer cells through interacting with Bcl-XL and regulating ROS production and drug sensitivity. Therefore, ETK may play an important role in regulating survival, migration and invasion by modulating multiple signaling pathways in bladder cancer cells. Immunohistochemistry analysis on tissue microarrays containing 619 human bladder tissue samples shows that ETK is significantly upregulated during bladder cancer development and progression and ETK expression level predicts the survival rate of patients with cystectomy. Taken together, our results suggest that ETK may potentially serve as a new drug target for bladder cancer treatment as well as a biomarker which could be used to identify patients with higher mortality risk, who may be benefited from therapeutics targeting ETK activity

Viral Etiologies of Hospitalized Acute Lower Respiratory Infection Patients in China, 2009-2013

Our findings could serve as robust evidence for public health authorities in drawing up further plans to prevent and control ALRIs associated with viral pathogens. RSV is common in young children and prevention measures could have large public health impact. Influenza was most common in adults and influenza vaccination should be implemented on a wider scale in China

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Funder: NCI U24CA211006Abstract: The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts

Evaluation of tuberculosis surveillance in Satun Province, Thailand, July 2011

Three main tuberculosis (TB) reporting systems were operating in Thailand: notifiable disease surveillance (R506), TB registration and control in Bureau of Tuberculosis (BTB) and TB report for reimbursement in National Health Security Office (NHSO). A cross-sectional study was conducted in Satun Province in July 2011 to determine whether the three systems responded well to the objectives of TB surveillance. Patients diagnosed with TB and received anti-TB drugs at least once in 2010 from three hospitals were compared with TB cases reported in three systems. In the hospitals, 170 TB cases, including 95 new smear positive pulmonary TB cases, were reviewed. Coverage and positive predictive value were 73% and 83% for R506, 87% and 100% for BTB, and 79% and 99% for NHSO respectively. Success rate (82%) of all cases was lower than that was reported in BTB (96%). Median duration from diagnosis to reporting in R506, BTB and NHSO were six, 61 and two days respectively. All systems had sufficient budget, human resources and regular training. In addition, all systems had good capacity to achieve the major objectives of TB surveillance and their specific objectives. However, the systems had total 295 variables which resulted in high workload for reporting. Integrating three systems as one national TB reporting system was recommended to improve coverage, timeliness and success rate